Detalhe da pesquisa
1.
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
Cell
; 185(3): 563-575.e11, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120664
2.
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.
Acta Neuropathol
; 146(6): 845-847, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37831210
3.
Specific Mutations in APC, but Not Alterations in DNA Damage Response, Associate With Outcomes of Patients With Metastatic Colorectal Cancer.
Gastroenterology
; 159(5): 1975-1978.e4, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730818
4.
Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting.
PLoS One
; 19(4): e0301989, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683764
5.
Tumor Volume Growth Rates and Doubling Times during Active Surveillance of IDH-mutant Low-Grade Glioma.
Clin Cancer Res
; 30(1): 106-115, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37910594
6.
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.
Cancer Discov
; 14(1): 49-65, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849038
7.
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.
Clin Cancer Res
; 30(10): 2272-2285, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488813
8.
Long-term Outcomes in Primary CNS Lymphoma After R-MVP and High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant.
Neurology
; 101(7): e710-e716, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344228
9.
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Eur Urol
; 83(1): 29-38, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115772
10.
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case Series.
Neurology
; 2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948444
11.
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.
Mol Oncol
; 16(22): 3994-4010, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087093
12.
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.
Mol Oncol
; 16(13): 2451-2469, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792282
13.
Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.
Oncogene
; 41(5): 671-682, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802033
14.
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.
Clin Cancer Res
; 28(2): 318-326, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667026
15.
The Impact of PIK3R1 Mutations and Insulin-PI3K-Glycolytic Pathway Regulation in Prostate Cancer.
Clin Cancer Res
; 28(16): 3603-3617, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670774
16.
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.
Cancer Discov
; 12(11): 2552-2565, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36048199
17.
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling.
Nat Commun
; 13(1): 6513, 2022 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316305
18.
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma.
Cancer Immunol Res
; 10(3): 303-313, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013003
19.
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors.
Clin Cancer Res
; 27(6): 1792-1806, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334906
20.
Genome Analysis and Replication Studies of the African Green Monkey Simian Foamy Virus Serotype 3 Strain FV2014.
Viruses
; 12(4)2020 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268512